Celebrate the 25th Annual National Cancer Survivors Day, June 3
The first Sunday in June each year for the past twenty-four years has been recognized as National Cancer Survivors Day, a celebration of cancer survivorship observed in communities and countries all over the world. The event is spear-headed by the non-profit National Cancer Survivors Day Foundation.
The Foundation offers a variety of support strategies to help the many hundreds of cancer-related organizations hosting National Cancer Survivors Day events. As their home page says,
"Participants [in National Cancer Survivors Day] unite in a symbolic event to show the world that life after a cancer diagnosis can be meaningful and productive."
They define a cancer survivor as "anyone living with a history of cancer – from the moment of diagnosis through the remainder of life." National Cancer Survivors Day allows others to see that their community features an active, productive cancer survivor population.
Find an event near you
To find an event near you, reach out to your local cancer treatment center, the American Cancer Society (Cancer.org) , or by hooking up with the Foundation …
- … on their homepage at ncsd.org
- … on Facebook at Facebook.com/CancerSurvivorsDay
- … on Twitter at @SurvivorsDay
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
